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Abstract
The cyclic antimicrobial lipopeptide daptomycin triggers the LiaFSR membrane stress response 
pathway in enterococci and many other Gram-positive organisms. LiaR is the response regulator 
that, upon phosphorylation, binds in a sequence specific manner to DNA to regulate transcription 
in response to membrane stress. In clinical settings, nonsusceptibility to daptomycin by 
Enterococcus faecium is correlated frequently with a mutation in LiaR of Trp73 to Cys 
(LiaRW73C). We have determined the structure of the activated Enterococcus faecium LiaR protein 
at 3.2 Å resolution and, in combination with solution studies, show that activation of LiaR induces 
formation of a LiaR dimer that increases LiaR affinity at least 40-fold for the extended regulatory 
regions upstream of the liaFSR and liaXYZ operons. In vitro, LiaRW73C induces phosphorylation-
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independent dimerization of LiaR and provides a biochemical basis for non-susceptibility to 
daptomycin by upregulation of the LiaFSR regulon. A comparison of the Enterococcus faecalis 
LiaR, Enterococcus faecium LiaR and the LiaR homolog from Staphylococcus aureus (VraR) and 
the mutations associated with daptomycin resistance suggest that physicochemical properties such 
as oligomerization state and DNA specificity, though tuned to the biology of each organism, share 
some features that could be targeted for new antimicrobials.
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Introduction
The continuing rise and persistence of multi-drug resistant pathogens poses substantial 
burdens on the clinical community. Vancomycin-resistant enterococci (VRE) are a leading 
cause of Hospital-Associated Infections (HAI) and are among the most recalcitrant 
nosocomial pathogens. VRE often develop resistance to a variety of antibiotics making the 
treatment of infections challenging [1]. In particular, E. faecium is the most multidrug-
resistant of the enterococcal species affecting critically ill patients. Indeed, the Infectious 
Diseases Society of America (IDSA) has included E. faecium as one of the “no-ESKAPE” 
pathogens [2], against which new drugs are urgently needed. With therapeutic options 
dwindling, the cyclic lipopeptide daptomycin (DAP) has become one of the last remaining 
bactericidal options for the treatment of multi-drug resistant enterococcal infections. 
Unfortunately, the clinical efficacy of DAP is being challenged by the development of 
resistance which tends to emerge during therapy [3-5].
Daptomycin is a cyclic lipopeptide that targets the cell membrane of Gram-positive bacteria 
in a calcium-dependent manner becoming a de facto cationic antimicrobial peptide [6]. 
Recent studies have suggested that the association of the calcium-daptomycin complex to 
the bacterial cell membrane depends on the presence of phosphatidylglycerol-rich regions in 
the outer leaflet of the cell membrane with a marked preference for the septa of dividing 
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cells [7]. Upon insertion into the membrane, daptomycin disrupts membrane homeostasis 
leading to rapid cell death [7-9].
Studies using Bacillus subtilis, enterococci and methicillin-resistant Staphylococcus aureus 
have suggested that daptomycin disrupts membrane potential via leakage of small ions such 
as intracellular potassium resulting in alterations in cell physiology and cell division [7, 
10-12]. The biochemical mechanism for DAP resistance is still under investigation but it is 
apparent that there are distinct phenotypic differences associated with the emergence of 
daptomycin non-susceptibility between E. faecium, E. faecalis and S. aureus [6, 7, 13]. To 
date, there are at least two distinct biochemical mechanisms for cells to reduce their 
susceptibility to daptomycin. In S. aureus and B. subtilis changes in the cell envelope appear 
to increase the overall positive charge of the cell surface, repelling the antibiotic from the 
membrane target (‘repulsion’) [6, 14, 15]. In contrast, in E. faecalis there is evidence for a 
‘diversion’ mechanism in which DAP is diverted away from the division septa [6, 16, 17]. In 
the case of E. faecium, higher levels of daptomycin resistance appear to be associated more 
strongly with the repulsion mechanism while strains of E. faecium that are susceptible to 
lower concentrations seem to be able to divert the antibiotic molecule, suggesting that 
molecular strategies for resistance between species is more complex than may have been 
anticipated [16, 17]. One of the most important mediators of daptomycin resistance in 
enterococci is the three-component LiaFSR signaling pathway [6, 16, 18]. Activation of this 
system triggers an adaptive response to the antibiotic attack by leading to downstream 
changes in the transcription of several operons, such as liaFSR and liaXYZ to alter 
membrane homeostasis resulting in resistance to DAP and antimicrobial peptides [18, 19]. 
The liaFSR operon encodes LiaS, a membrane bound kinase; LiaF, a protein suggested to 
inhibit LiaS phosphorylation activity in the absence of membrane stress; and LiaR, a 
response regulator that is phosphorylated by LiaS to alter transcription from the LiaR 
regulon. Deletion of liaR in both E. faecalis and E. faecium abolishes the adaptive response 
and restores susceptibility to daptomycin and antimicrobial peptides, supporting the pivotal 
role of LiaR in the mechanism of resistance [16]. LiaR is comprised of two functional 
domains: a receiver domain (residues 1-139) that can be phosphorylated and a DNA binding 
domain (residues 140-210) with a Helix-Turn-Helix motif that recognizes specific regulatory 
DNA sequences via formation of a DNA binding domain dimer. Recently, we demonstrated 
that activation of LiaR in E. faecalis (Efc LiaR) promotes formation of a LiaR tetramer that 
allows LiaR to recognize complex upstream regulatory regions that extend beyond the 
predicted consensus sequence. Additionally, we showed that an adaptive mutation isolated in 
response to DAP exposure (Efc LiaRD191N) “hyperactivates” the liaFSR system leading to 
resistance [19]. Interestingly, emergence of daptomycin resistance in clinical isolates of E. 
faecium is highly associated with a Trp73 to Cys substitution in LiaR (Efm LiaRW73C) [17]. 
Recently published whole genome sequence analysis of 19 E. faecium clinical isolates with 
DAP MICs between 3 to 32 μg/ml indicate that a Trp73 to Cys substitution in response 
regulator LiaR was the most frequent change in epidemiologically unrelated clinical isolates 
of E. faecium with DAP MICs ≥ 3 μg/ml. Efm LiaRW73C is typically found with a second 
mutation in the kinase LiaST120A suggesting a potential epistatic relationship [17].
A critical difference between the Efc LiaRD191N and Efm LiaRW73C is that the “triggering” 
mutations associated with daptomycin non-susceptibility are located in different domains of 
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the protein, suggesting that the mechanism of activation associated with LiaR substitutions 
in DAP resistant clinical strains may differ between E. faecalis and E. faecium.
Using a combination of biophysical and structural approaches we were able to compare and 
contrast the molecular details of the adaptive mutations that lead to decreased daptomycin 
susceptibility in E. faecalis and E. faecium. We show that in the absence of phosphorylation, 
Efm LiaR exists predominately as a monomer and that activation with the chemical 
phosphomimic BeF3− strongly favors formation of a dimer with high affinity for extended 
DNA recognition sequences. This finding contrasts with our earlier study of Efc LiaR in 
which the protein undergoes a dimer to tetramer transition upon phosphorylation [19]. Taken 
together, our results show that while there are similarities between E. faecium LiaR, E. 
faecalis LiaR and the LiaR homolog VraR of S. aureus, there are substantial and 
consequential physicochemical differences. New small molecules that might target LiaR to 
suppress the membrane stress response of these organisms and thereby extend the efficacy of 
DAP or other membrane damaging agents should be thoughtfully directed at the common 
molecular attributes of LiaR and the LiaR homolog VraR to have the broadest applicability.
Results
Beryllofluoride (BeF3−) stabilizes E. faecium LiaR as a dimer
Phosphorylation-dependent oligomerization and consequent activation of response 
regulators can vary widely between organisms. Based on a comparison of the E. faecium 
LiaR sequence with that of E. faecalis LiaR and other response regulators from NarL/FixJ 
subfamily, such as S. aureus VraR, B. subtilis LiaR, E. coli NarL, FixJ, Asp-54 was 
identified as a potential site for phosphorylation [19, 20].
To elucidate the changes in quaternary structure associated with phosphorylation, we used 
Beryllium trifluoride (BeF3−) binding to LiaR as a functional mimic for phosphorylation 
[21]. BeF3−, made in situ, is a simple and general method to reproduce a stable 
phosphorylated-like state [22]. Using sedimentation equilibrium analytical 
ultracentrifugation (SEQ), we determined the oligomerization state of full length Efm LiaR 
as well as the isolated receiver domain (residues 1-139 and referred to hereafter as LiaRRD) 
with and without BeF3− and the DNA binding domain (residues 140-210 and referred to 
hereafter as LiaRDBD) (Figure 1, S1). Interestingly, the oligomerization of the full-length 
Efm LiaR differs both qualitatively and quantitatively from what we reported previously for 
E. faecalis LiaR [19]. Our analytical ultracentrifugation studies suggest that inactivated Efm 
LiaR exists nearly exclusively as monomer in solution with a dissociation constant of Kd 
>1600 μM and that addition of BeF3− promotes dimer formation (Kd = 15 μM) (Table 1). We 
estimated that the propensity towards dimerization is increased at least 2 orders of 
magnitude by the formation of the BeF3−:LiaR complex. Activation of Efm LiaR by BeF3− 
produces a monomer↔dimer transition with no observable higher order oligomers like 
tetramers. To confirm these results we also performed a sedimentation velocity analytical 
ultracentrifugation experiment with solutions containing 50 μM Efm LiaR or 5 μM Efm 
LiaR respectively. The sedimentation velocity data was interpreted using a local continuous 
distribution model searching for species corresponding to 0.5 to 15 Svedbergs. Using this 
model, we observe two main species with sedimentation coefficients of 1.4 S and 2.0 S 
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respectively. These two species have apparent molecular weights of 23.3 kDa and 40.9 kDa 
respectively, suggesting the two peaks represent monomeric and dimeric populations of 
LiaR (Figure S2). By integrating the peaks in the c(S) distribution separately we estimate the 
fraction of LiaR that is present as a homodimer in the 5 μM and 50 μM samples to be 0% 
and 11% respectively, providing further evidence that unphosphorylated Efm LiaR has only 
a very weak propensity to dimerize.
To further characterize the behavior of Efm LiaR in solution, we also analyzed the 
contribution of isolated LiaR domains to oligomerization in the presence and absence of 
BeF3−. Sedimentation equilibrium analysis of the domains in the absence of BeF3− showed a 
weak but detectable propensity for dimerization by the Efm LiaRRD (Kd = 676 μM) and a 
much stronger dimerization propensity for the Efm LiaRDBD (Kd = 0.4 μM). Addition of 
BeF3− increased the extent of dimerization formation of Efm LiaRRD by a remarkable 198-
fold to a Kd of 3.4 μM. These analyses indicate that while DNA binding domain is capable 
of homodimerization (Kd = 0.4 μM), the oligomerization of the Efm LiaRRD is strongly 
dependent on phosphorylation, consistent with a regulatory role in vivo.
LiaRW73C from a daptomycin-resistant clinical isolate of E. faecium promotes 
phosphorylation-independent dimerization of the LiaR protein
Having established that phosphorylation controls a monomer↔dimer transition for the wild-
type Efm LiaR, we sought to investigate whether the substitution of Trp73 to Cys in LiaR 
(the most common LiaR change associated with daptomycin resistance in E. faecium clinical 
isolates) [17, 23] has a direct effect on LiaR oligomerization. Using sedimentation 
equilibrium experiments of the full length Efm LiaRW73C and receiver domain alone (Efm 
LiaR(RD)W73C) in the presence and absence of BeF3−, we showed that the W73C 
substitution promotes phosphorylation-independent dimerization of Efm LiaR. Indeed, as 
mentioned above, in the absence of BeF3− we were unable to measure any significant 
dimerization of the full length Efm LiaR. In contrast, Efm LiaRW73C showed a readily 
detectable level of dimerization (Kd=182 μM), suggesting that the Trp73 to Cys substitution 
strongly stimulates phosphorylation-independent dimerization. This phenomenon was 
further confirmed by our studies on Efm LiaR(RD)W73C which showed a 7-fold higher 
propensity for dimerization compared to the wild type Efm LiaRRD. The higher propensity 
to form a dimer was also observed by sedimentation velocity analytical ultracentrifugation 
(Figure S3). Using a local continuous c(S) distribution model we could interpret the relative 
size of the populations of monomer, dimer and larger oligomeric species for the 50 μM and 5 
μM samples tested. In agreement with the sedimentation equilibrium results, we observed a 
greater proportion of the protein in the homodimer state for the W73C mutant of LiaR, 
relative to the wild type protein. For the 50 μM protein sample 59% of the total protein had a 
sedimentation coefficient of 1.8 S corresponding to monomeric LiaR (apparent MW of 27 
kDa). 34% of the total protein is the homodimer form with a sedimentation coefficient of 2.8 
S and apparent MW of 48 kDa. We additionally observed a small fraction of the protein at 
larger sedimentation coefficients of 4.2 S, 5.5 S and 6.6 S and with apparent molecular 
weights of 90 kDa, 134 kDa, or 178 kDa respectively that total 8% of the protein population 
in the 50 μM. These apparent molecular weights correspond to tetramer, hexamer and 
octamer species of LiaR suggesting the W73C mutation can promote the formation of larger 
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species. As we did not observe these species by size exclusion chromatography it is unclear 
if these are non specific aggregation effects or a biologically relevant species that might exist 
in E. faecium. Gel filtration studies further corroborate our finding that Efm LiaRW73C 
promotes formation of a phosphorylation independent dimer (Supplementary Information, 
S4).
Interestingly, and unlike the wild type protein, we could not detect any further increase in 
dimerization of the full length Efm LiaRW73C in the presence of BeF3−. Instead, the best fit 
for dimerization was with a Kd of 236 μM, which is similar to the dimerization constant 
observed for Efm LiaRW73C in the absence of BeF3−. This finding is consistent with a model 
in which the mutation of Trp-73 to cysteine has effectively stimulated the formation of the 
activated LiaR dimer to the same extent as phosphorylation. It is also possible that the 
increased propensity for dimerization leads to an increased efficiency of phosphorylation by 
LiaS. Thermal denaturation studies show that Efm LiaRW73C is 4.7 °C less stable than wild 
type consistent with a model in which the adaptive mutation has potentially destabilized 
contacts between the receiver and DNA binding domains (Supplementary Information, S5).
When we tested the effect of BeF3− on the receiver domain alone (Efm LiaR(RD)W73C), we 
observed a marked increase in dimerization. Indeed, the Kd of dimerization for Efm 
LiaR(RD)W73C increased from 94 to 0.8 μM. Our results suggest that the DNA binding 
domain may also have a role in determining the extent of dimerization induced by either 
phosphorylation or the presence of BeF3−. Thus, in the absence of the DNA binding domain, 
the extent of dimerization is further enhanced by BeF3− in a manner that is not observed for 
the intact protein.
The crystal structure of full length Efm LiaR is a dimer poised to make interactions with its 
target DNA
We determined the X-ray crystal structure of Efm LiaR in the beryllofluoride-activated state 
to reveal information about the conformational changes induced by phosphorylation. 
Response regulators have been classified into several common types including the NarL-type 
that includes a common helix-turn-helix (HTH) motif, OmpR-type that includes a winged 
HTH motif, Spo0A-type, and Fis-like [24]. The structure of Efm R494 LiaR suggests that 
this protein belongs to the NarL/FixJ subfamily of proteins [20, 24].
The Efm LiaR:BeF3− structure contains four protomers in the asymmetric unit each with a 
BeF3− bound to the predicted phosphorylation site at Asp54 (Figure 2, S6). Essentially, a 
pair of activated dimers are observed in the asymmetric unit. Based on homology to other 
NarL-type response regulators residue Thr-82 and aromatic residue Tyr-101 would be 
predicted to play a direct role in the activation mechanism through their hydroxyl groups 
[25]. In the Efm LiaR:BeF3− structure residues Thr82 and Tyr101 are oriented toward the 
predicted phosphorylation site, adopting inward positions consistent with BeF3− stimulated 
formation of the active phosphorylated state (Figure 3). Within the active site, BeF3− is 
stabilized by a single Mg2+ ion and the backbone amide of Val56. Previous studies have 
suggested that the residue equivalent to Val56 is one of the structural determinants that 
influence the auto-dephosphorylation rate of response regulator proteins [26, 27]. BeF3− is 
also in a position to make hydrogen bonds to Thr82 and Ser83 and a salt bridge to Lys104 
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(Figure 3a,b). As shown in Figure 2, each protomer has a canonical regulatory domain fold 
with the (ßα)5 arrangement and Helix-Turn-Helix DNA binding domain seen in other NarL-
like proteins [20, 24, 25].
Helix α-6 followed by short loop creates a flexible linker between the receiver and DNA-
binding domains. Interestingly, the arrangement of the DNA binding domains is 
substantially different from the activated form of S. aureus VraR. Presumably this reflects 
the mobility of the DNA binding domains in both structures when DNA is not present. Our 
BeF3− activated structure is consistent with full-length Efm LiaR poised in a configuration to 
interact with DNA. Two of the four DNA binding domains observed in our structure are 
extended well away from the receiver domain dimer and illustrate the conformational 
flexibility of the linker regions that join them to the domain (Figure 2).
In the Efm LiaR:BeF3− co-structure, two receiver domain dimers (indicated as chains A-F 
and B-C respectively) are observed in the asymmetric unit (Figure 4a-b). The major 
interaction surface between neighboring receiver domains buries ~1034 Å2 of solvent 
accessible surface area through the α4-ß5-α5 interfaces. The protein-protein interactions of 
the two receiver domains involves 3 potential salt bridges and 3 hydrogen bonds that were 
also observed in the S. aureus response regulator VraR [19] and are presumed to stabilize the 
quaternary structure. Like Efm LiaR, S. aureus VraR crystallized as two pairs of receiver 
domain dimers (Figure 4c-d). In the case of VraR, the DNA binding domains formed 
additional dimer interfaces but not between the two proteins that comprise the receiver 
domain dimer but rather as a domain swap (Figure 4d). In the Efm LiaR:BeF3− co-structure, 
each DNA binding domain also formed additional dimer interfaces (Figure 4e-f) but with 
DNA binding domains contributed from symmetry related molecules and not to the one that 
is contributed by the proximal LiaR protomer that comprises the LiaR:LiaR dimer (a domain 
swap). Thus, the domain swap in the activated VraR tetramer structure and Efm LiaR:BeF3− 
co-structure are very different and may reflect flexibility of linker regions that join the DNA 
binding domains to the receiver domain[28]. The arrangement of the Efm LiaR:BeF3− DNA 
binding domains is likely to be a crystal packing artifact but shows that DNA binding 
domains can explore a very large volume, a feature that may be important to binding the 
large extended DNA at the promoter.
The phosphorylation-triggered dimerization surface of E. faecium LiaR is similar to that of 
S. aureus VraR
The receiver domain of Efm LiaR forms a dimer that associates through a hydrophobic 
interface comprised of α1-α5 that buries 692 Å2 (Figure 3a,c). This dimerization interface, 
lined by hydrophobic amino acids Val13, Val17, Ser19, Tyr20, Lys104, Ala108 is similar to 
those found in the structures of B. subtilis DesR [27] and VraR [28] suggesting that these 
interfacial residues are well conserved among members of NarL subfamily.
Earlier studies have shown that phosphorylation promotes dimerization through different 
surfaces among different response regulators. While members of the PhoB/OmpR family 
[29, 30] and FixJ [28, 31] utilize the hydrophobic surface of the α4-β5-α5 interface for 
phosphorylation triggered dimerization, the NarL transcription factor from E. coli [32], the 
cell-density-responsive transcription factor LuxR from S. aureus, S. aureus VraR [28] and B. 
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subtilis DesR [27] employ a novel α1-α5 contact surface. An analogous involvement of 
helix α1 in intermolecular contacts has also been established in the M. tuberculosis NarL 
[33] and E.coli UhpA [34].
In the VraR structure it has been suggested that movement of α-6 is part of the activation 
mechanism in which the angle of the helix α-6 changes by 35° in response to 
phosphorylation [28]. To determine whether the interface for the α-6 helices packing against 
each other is conserved between VraR and Efm LiaR after activation, we superimposed the 
receiver domain structures of the two proteins. Based on this analysis, we concluded that the 
dimerization interaction is similar between S. aureus VraR and E. faecium LiaR with an 
overall root mean square deviation (r.m.s.d.) of 1.14 Å. [35].
Efm LiaR DNA recognition motifs upstream of the putative promoters for both the Efm 
liaFSR and the liaXYZ operons are comparable in size and organization to those of E. 
faecalis
Our previous studies revealed that Efc LiaR recognizes an extended stretch of DNA that 
extends beyond the proposed canonical consensus sequence T(X)4C(X)4G(X)4A, suggesting 
a more complex level of regulatory control for target operons [19]. We previously showed 
that in E. faecalis such consensus sequences are present upstream of the liaFSR and liaXYZ 
operons [19]. Inspection of the 5’ region of the Efm liaXYZ and liaFSR operons revealed 
three and four potential consensus sites, respectively. We used DNA Footprint Analysis by 
Automated Capillary Electrophoresis (DFACE) to identify the DNA sequences protected by 
activated Efm LiaR. Our initial studies indicated that the unphosphorylated Efm LiaR 
protein had no measurable affinity for the DNA upstream of either operon. In contrast, when 
Efm LiaR is activated by formation of the Efm LiaR:BeF3− complex, protection of DNA 
across extended regions of DNA upstream of the liaXYZ and liaFSR operons could be 
identified readily. We mapped the LiaR binding region from −292 to +65 for liaXYZ and 
−281 to +98 for liaFSR. The BeF3− activated protein revealed a concentration dependent 
region of protection for both operons with no observable protection at 0.5 μM, slight 
protection at 2.5 μM, (data not shown) and significant protection at 5.0 μM and 50 μM 
protein (Figure 5a, c). The 50 μM Efm LiaR concentration had a slight increase in protection 
and cleavage at most bases as compared to 5.0 μM. Interestingly, Efm LiaR protects only 
one canonical binding motif of T(X)4C(X)4G(X)4A for both operons. As shown in Figure 5, 
the consensus binding regions starting at positions −80 and −62 respectively for liaXYZ and 
liaFSR are protected by the Efm LiaR:BeF3− complex. The other potential consensus 
binding sites did not show protection (data not shown).
While both liaFSR and liaXYZ show binding at a single consensus binding sequence, the 
overall organization of the protected regions with respect to each other is very different. 
Based on sequence homology to other response regulators containing a canonical helix-turn-
helix DNA binding motif, the active species of Efm LiaR would be expected to dimerize and 
have site size of ~21 nucleotides. In contrast, the contiguous protection site for the Efm 
liaXYZ promoter extends from position −120 to −75 (about 45 bp) and includes the 
predicted consensus region (−95 to −80) and nucleotides from −96 to −120. We refer to this 
additional region outside the consensus sequence as the “secondary site” and, taken together, 
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make up the extended DNA recognition element recognized by LiaR family members 
(Figure 5a). In this case the extended protected sequence over a site size of 45 base pairs 
suggests binding of two dimers or a single tetramer.
For the liaFSR promoter only about 29 (−77 to −48) nucleotides are protected (Figure 5c). 
The size of the DNase footprint is comparable to that observed for the Efc liaFSR operon. 
As we observed for the Efc liaFSR operon, in addition to the predicted consensus site (−77 
to −62), there is a distinct protection for a secondary site from −63 to −48. Since the 
protected region for Efm liaFSR is smaller (29 base pairs) than that of Efm liaXYZ (45 base 
pairs) the evidence for two dimers of LiaR binding to the Efm liaFSR operon is less clear. In 
the comparable Efc liaFSR operon, the inclusion of the extended region was necessary for 
high affinity [19]. It is also interesting to note that the organization of the liaFSR and 
liaXYZ operons is very different. For liaXYZ the secondary site is 5’ of the consensus site 
while in liaFSR the secondary site is 3’ of the consensus sequence (Figure 5). This 
organization was also observed in E. faecalis.
While the protection sites of LiaR in E. faecium for both operons are identical in size for the 
closely related species, E. faecalis [19], the recognition elements for the E. faecium liaFSR 
and liaXYZ operons are shifted 4 and 16 base pairs respectively closer to the translation start 
site.
DNase hypersensitive sites suggest long range changes to DNA structure upon LiaR 
binding
In addition to protection from DNase cleavage, protein binding can also induce changes in 
DNA structure that increase nuclease sensitivity (hypersensitivity). Hypersensitivity is often 
correlated with bending or kinks induced in the DNA structure that render the 
phosphodiester backbone more accessible. As shown in Figure 5, both consensus binding 
regions share a strong hypersensitive site at the T immediately 3’ of the A in the consensus 
sequence (T(X)4C(X)4G(X)4A) a feature also observed in the homologous E. faecalis 
sequences.
Additional evidence for long range DNA structural changes suggestive of DNA bending can 
be seen as subtle hypersensitive sites at positions −85 and −53 of the liaFSR operon. As in 
the Efm liaFSR protection pattern, the protected region within liaXYZ operon is flanked by 
two strong hypersensitive sites at −79 and −114. These additional hypersensitive sites (−85 
and −53 within liaFSR operon and −114 within liaXYZ operon) were not observed 
previously in the E. faecalis species. In E. faecalis, we had previously identified a region of 
marked hypersensitivity to nuclease digestion located 35 bases downstream of the liaXYZ 
consensus sequence [19]. Although this specific hypersensitive site was not present in E. 
faecium there is a strong and consistent hypersensitive site at positions (−4) AGCG (−1) 
(Figure 5e) of Efm liaFSR. Thus, our findings suggest that LiaR can significantly change the 
structure of DNA up to 50 bp downstream of the binding site, which could modify 
transcription rates.
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The adaptive mutant Efm LiaRW73C binds more tightly to DNA binding sites within the 
liaXYZ and liaFSR operons
We have reported previously that the adaptive mutant LiaRD191N that is associated with 
daptomycin resistance in E. faecalis S613, markedly increases LiaR affinity for target DNA 
sequences and thereby upregulates transcription of LiaR-controlled genes [19]. Here, we 
tested the hypothesis that Efm LiaRW73C may have a similar effect on binding to specific 
DNA sequences. Using MicroScale Thermophoresis (MST), we measured the affinity of 
LiaR for both the consensus and adjoining secondary sites separately as well as for the entire 
protection region that were recovered from our DNA footprint analysis (Figure 6). We found 
that Efm LiaRW73C has an increased affinity for DNA target sites compared to wild-type 
LiaR to both the consensus and secondary sequences of the liaXYZ operon, consistent with 
our earlier observation of increased affinity for DNA by the adaptive mutant Efc LiaRD191N 
(Table 2, Figure 6a). However, the affinities of full-length Efm LiaRW73C toward cognate 
DNA measured in this study are generally weaker than those reported for Efc LiaRD191N. 
Unlike Efc LiaRD191N, which had higher affinity for the consensus site (0.39 ± 0.03 μM), 
Efm LiaRW73C binds with comparable affinity to both the consensus and secondary sites 
(9.9±0.6 μM and 16.7±0.4 μM, respectively).
We would have also expected Efm LiaRW73C to bind with higher affinity to the entire 
contiguous protected region identified by DNA footprinting for the liaXYZ operon. 
However, the binding affinity was comparable to that for the consensus site alone (liaXYZ: 
Kd = 13.7±1.3 versus 9.9±0.6 μM) (Table 2). Interestingly, the binding isotherms for the 
entire protected region indicate a clear positive cooperativity in binding as well. It is not 
clear whether the apparent cooperativity results from direct dimer-dimer interactions of LiaR 
dimers at the DNA or from a strong shift of the LiaR monomer-dimer equilibrium in the 
presence of DNA. We favor the latter as the apparent cooperativity could be observed on the 
smaller 26 nucleotide DNA substrates that would not accommodate two dimers.
While DNA protection studies revealed that Efm LiaR had regions of protection that 
extended well beyond the consensus binding sequence, the overall affinity for the liaFSR 
and liaXYZ consensus sequences was quite different. The affinity of LiaRW73C for a 26 
nucleotide DNA sequence extending from −83 to −58 (Figure 5c, d) of liaFSR was at least 
10–fold lower than the comparable liaXYZ consensus binding site (Table 2). To test whether 
the additional sequences protected outside the canonical liaFSR consensus binding site are 
important for Efm LiaR binding, we extended the DNA sequence an additional 6 nucleotides 
toward the translation start site and measured the affinity for this extended 32 nucleotides 
protected region by MST. Efm LiaRW73C binds to the extended sequence at a micromolar 
concentration Kd=18.2±1.1 μM or about 5-fold higher than the shorter consensus site alone. 
The affinity for the entire contiguous protected region for Efm liaFSR (46 nucleotides, see 
Figure 5d) was comparable to that for the extended site Kd=13.3±1.3 μM (Table2). This is 
consistent with our earlier findings for Efc LiaR binding to the Efc liaFSR operon and 
confirming our earlier hypothesis that DNA sequences adjoining the canonical consensus 
sequence of the Efm liaFSR operon are also important for DNA binding.
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The DNA binding domain alone is not able to bind regulatory DNA sequences with high 
affinity
Our analytical ultracentrifugation studies had demonstrated that the Efm LiaRDBD were able 
to dimerize readily in solution implying that it might have been possible for the DNA 
binding domains alone to have high affinity for DNA. The binding of Efm LiaRDBD to the 
liaXYZ and liaFSR operon sequences did not generate enough fluorescence change to obtain 
reliable Kd suggesting extremely weak protein–DNA interactions. These results support our 
earlier observation that even though the DNA binding domain itself exists in solution as a 
dimer, with a Kd of 0.4 μM (Table 1), the receiver domain appears essential for specific 
DNA binding.
Discussion
Exploration of the membrane stress response pathways of the pathogens E. faecium, E. 
faecalis and S. aureus reveals many commonalities as well as significant differences that 
should frame discussions of new therapies and antimicrobials. Examination of LiaR from E. 
faecium and E. faecalis and its homolog from S. aureus, VraR suggests an interesting 
evolutionary flexibility in the response regulator quaternary structure. E. faecium LiaR and 
S. aureus VraR are largely monomeric and become dimeric upon phosphorylation to mediate 
the cell membrane stress response. In contrast, E. faecalis LiaR exists predominately as a 
dimer that oligomerizes to an active tetramer upon phosphorylation [19]. DNA footprinting 
analysis of upstream regulatory regions from all three organisms suggests extended 
footprints that extend beyond the simple predicted consensus sequence upon 
phosphorylation or activation by an adaptive substitution. In principle, such extended DNA 
binding regions could be bound as a pair of dimers or as a single tetramer in the case of Efc 
LiaR. In the crystal structures of both S. aureus VraR and Efm LiaR there are two pairs of 
dimers in the asymmetric unit that could reflect how they might bind to extended regions of 
DNA and produce DNA bending to facilitate recruitment of RNA polymerase. Indeed our 
DNA footprinting studies for both Efc and Efm LiaR suggest that LiaR binding induces 
strong DNase hypersensitive sites suggestive of DNA bending. If DNA recognition by this 
family of response regulators requires four copies of the protein to induce DNA bending and 
a consequent increase in transcription from target operons, then any mutation that favors 
oligomerization will effectively “turn on” the system. This has now been observed in the 
adaptive mutants Efc LiaRD191N and Efm LiaRW73C isolated in response to the 
antimicrobial peptide daptomycin.
Interestingly, the activating substitution in Efc LiaR occurs at position 73 of the receiver 
domain and is not at the dimerization surface of the receiver domain dimer. (Figure 7a). The 
fact that the adaptive mutation W73→C in Efm LiaR is distant from the molecular interfaces 
comprising a LiaR dimer suggests an indirect role in favoring the dimerization competent 
monomer (e.g., the phosphorylated state). Based on our SEQ results in the absence of 
BeF3−, the full length LiaR protein is monomeric. In contrast, the sedimentation equilibrium 
analysis showed a weak but detectable dimerization propensity (Kd = 676 μM) for the LiaR 
receiver domain (LiaRRD) and a much stronger propensity for the DNA binding domain 
(LiaRDBD) to dimerize (Kd = 0.4 μM). Based on these results, we suggest a model where the 
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receiver domain and DNA binding domain interact with each other in the unphosphorylated 
LiaR protein, stabilizing the monomeric state of the protein and preventing dimerization of 
either the receiver domains or the DNA binding domain (“closed” state). However, 
phosphorylation dependent conformational changes or the substitution W73C in the receiver 
domain may promote the dissociation of the receiver domain from the DNA binding domain, 
allowing dimerization of both the receiver domain and the DNA binding domains of two 
LiaR protomers. A closed state has been observed previously in crystal structures of the 
unphosphorylated VraR and NarL proteins [28, 36]. In these reported structures, the 
dimerization surface of the DNA binding domain helix α-10 of VraR or helix α-9 of NarL 
were found to be buried against the receiver domain of the respective protomer to stabilize a 
closed monomer conformation. Although the exact amino acids involved in this interdomain 
interface are not conserved across the NarL/FixJ family of response regulators, the general 
paradigm has been observed in other family members [27].
In the absence of a structure for the full length unphosphorylated wild type E. faecium LiaR, 
we mapped the Efm LiaRW73C onto the VraR (PDB ID 4GVP)/NarL (PDB ID 1RNL) 
structures. As shown in Figure 7b, if our unphosphorylated LiaR structure resembles the 
inactive NarL but not VraR structure, the Trp73 is in the interfacial contact surface of the 
receiver to DNA binding domain. Thus the molecular surface comprised in part by Trp73 
may be important for stabilizing the closed monomer conformation where the receiver 
domain interacts with the DNA binding domain of the same protomer chain. The W73C 
substitution may weaken the interface between the receiver domain and the DNA binding 
domain, shifting the equilibrium from the closed state to an open state where the receiver 
and DNA binding domains have a higher propensity to dimerize with another LiaR 
monomer to form the activated dimer. Alternatively, we cannot rule out the possibility that 
the molecular dynamics of the receiver domain is altered in a more indirect manner to shift 
the LiaR ensemble towards a state that more closely resembles the phosphorylated state.
There are at least two biological contexts where increased dimerization can lead to 
upregulation of the LiaR regulon. The most obvious scenario is one in which LiaRW73C 
increases phosphorylation independent dimerization to constitutively hyperactivate the 
LiaFSR stress response pathway. This LiaS independent constitutive hyperactivation 
mechanism was observed for the Efc LiaRD191N adaptive mutant [19]. It is puzzling 
however that Efm LiaRW73C does not actually confer the same extent of dimerization as 
BeF3− stimulated wild type Efm LiaR (wild type Efm LiaR dimerization Kd was 15 μM 
compared to 236 μM for Efm LiaRW73C). Since in vivo concentrations of LiaR are estimated 
to be in the low micromolar range [37], the weak in vitro dimerization of Efm LiaRW73C is 
less than expected for constitutive hyperactivation. Alternatively, the Efm LiaRW73C mutant 
may interact more efficiently with its cognate kinase LiaS to produce a higher extent of 
phosphorylation than the comparable wild type LiaR interaction with LiaS. This alternative 
possibility is made more attractive by the observation that the Efm LiaRW73C mutation has 
always been identified with a LiaST120A in clinical daptomycin non-susceptible isolates 
[17]. In the case of Efc LiaRD191N, a concomitant second mutation in the Efc LiaS protein 
has not been observed. Thus, there may be at least two distinct classes of adaptive mutations 
through changes in LiaR, a constitutive phosphorylation-independent hyperactivation type 
(as seen for Efc LiaRD191N) and a second type that promotes more efficient phosphorylation 
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by LiaS that might include Efm LiaRW73C and that may be frequently observed in epistatic 
combination with sunbstitutions in LiaS.
If adaptive LiaR substitutions that favor oligomerization confer additional resistance to 
membrane stress, then, it is also likely that any small molecule that destabilizes 
oligomerization will increase susceptibility. Support for this hypothesis is observed readily 
in a recently described Efc [16] liaR knockout. When Efc liaR is removed, cells become 
hypersusceptible to daptomycin suggesting that LiaR could be a good target for new drugs 
that would complement existing antibiotics to maintain their long term efficacy by blocking 
the evolution of resistance through liaR [16].
Evolutionarily, there appears to be a spectrum of oligomeric answers to the question of how 
to bind these specific and extended DNA sequences. We have now observed both a 
monomer↔dimer and a dimer↔tetramer transition upon phosphorylation depending on the 
species. In all cases however, the DNA regulatory region is extended. Some organisms like 
S. aureus and E. faecium may shift the equilibrium towards the monomer while others like 
E. faecalis start as a dimer (that presumably does not bind DNA with high enough affinity to 
activate as a dimer alone) and then activate transcription as a tetramer. The facile nature of 
these equilibrium shifts can be seen readily by the single point mutations that dramatically 
change the oligomeric state (e.g. LiaRD191N and LiaRW73C in E. faecalis and E. faecium, 
respectively) (Figure 8)
More recently, a new Efm LiaR mutant Efm LiaRS19F has been identified in DAP non-
susceptible enterococci isolated from an immunocompromised patient suggesting that 
mutations within the receiver domain may be more common in E. faecium [38]. Mapping 
the recently discovered S19F substitution in the response regulator Efm LiaR onto our LiaR 
three-dimensional crystal structure (Figure 7a) revealed that this mutation is within the 
receiver domain dimerization interface. Based on our studies, the Efm LiaR S19F 
substitution may also increase oligomerization of LiaR to form a constitutively activated 
dimer with high affinity for the extended DNA regulatory sequence even in the absence of 
phosphorylation, leading to increased daptomycin resistance. If single point mutations can 
produce such large changes then it is not surprising that evolution has tuned these systems in 
particular niches. What might be surprising is that E. faecium would be so different from E. 
faecalis but perhaps this is the bias introduced by nomenclature rather than biology. E. 
faecium (GenBank accession number: WP_002348688.1) is 60.5 % identical to S. aureus 
(GenBank accession number: WP_000153535.1) while E. faecalis (GenBank accession 
number: EFE19096.1) is 59.7 % identical to S. aureus. E. faecalis and E. faecium 
themselves share 84.3% identity and thus there is substantial genomic variability to allow for 
these surprising differences (Figure S7). For example, E. faecalis LiaR has a deletion within 
the N-terminal ß1 strand (Figure S7) that is not present in E. faecium LiaR or S. aureus 
VraR. The truncation at the N-terminus is unusual within the NarL/FixJ subfamily and 
further highlights that even among closely related species there may be variability within 
protein structure with important consequences for protein function.
Interestingly E. faecium in the initial stages (only when the LiaFSR mutation occurs) is able 
to carry out both diversion and repulsion strategies while S. aureus favors repulsion and E. 
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faecalis favors diversion. These distinctive phenotypic changes suggest E. faecium may have 
some quite unique responses to membrane stress that contrasts markedly with its closely 
related peers.
Experimental procedures
Expression and purification of response regulator R494 LiaR and variants from E. faecium
The genes encoding full length LiaRW73C R494, receiver domain (RDW73C, residues 1-139) 
and DNA binding domain (DBD, residues 140-210) were amplified by PCR from genomic 
DNA R494, cloned into pETDuet vector and expressed in Escherichia coli BL21 (DE3) cells 
using LB medium. Site-directed mutagenesis of LiaR was performed by incorporation of 
mutations into the plasmid by inverse PCR with standard primers designed an overlapping 
orientation. The proteins were purified with a nickel affinity column (GE Healthcare) 
followed by the anion-exchange chromatography and gel filtration for the final step as 
described previously work [19]. N-terminal SUMO peptide (within the 6×His tag) was 
removed by treatment with His-tagged SUMO protease.
DNA footprint analysis by automated capillary electrophoresis (DFACE)
The 379-bp fluorescent labeled DNA probe for the R494 E. faecium liaFSR operon and 357-
bp fluorescent labeled DNA probe for the R494 E. faecium liaXYZ operon were generated 
with PCR amplification with the primers 5’-(VIC)-aatgattctcctatcgcgcaagca-3’ and 5’-
(FAM)-actaaaagcaaaaatccagtattg-3’ for liaFSR operon and 5’-(VIC)-
agcgttgatcctctggtttattga-3’ and 5’-(FAM)-aagccttcttcagtcgaaaggatt-3’ liaXYZ operon from 
Applied Biosystems (Grand Island, NY) as described previously [19, 39, 40]. Briefly, full 
length of Efm LiaR protein activated with the BeF3− at 0.5, 2.5, 5 μM and 50.0 μM was then 
incubated with respective fluorescent labeled DNA probe in Binding Buffer (50 mM Tris pH 
7.5, 300 mM NaCl, 10 mM MgCl2, and 0.3 mM DTT, 20% (v/v) glycerol, 0.05% (v/v) 
Tween-20) for 10 min. After this incubation, DNase I (New England Biolabs Inc., Ipswich, 
MA, 2 U/μl) digestion was performed. The reaction was then stopped by adding EDTA to a 
final concentration of 5 mM following by incubation at 75°C for 10 min. Control digestions 
with the probe were performed in the absence of the protein. The DNA fragments were 
purified with a QIA-quick PCR purification kit (Qiagen, Valencia, CA) and then sent to the 
Plant-Microbe Genomics Facility for further analysis. The resulting electropherograms from 
the DFACE assay were analyzed with the software GeneMapper 4.0 set to normalize all 
samples to the sum of the signal of all samples. In addition, the histograms were further 
normalized by subtracting the height of the equivalent peak (same Bin) in the negative 
control from the sample, i.e. each bar is the difference between sample and negative control. 
Data reported utilized fragments/strand labeled with VIC dye. Nucleotide positions refer to 
the region of LiaR binding on the DNA relative to the translation start site of LiaX or LiaF, 
respectively. DNA footprinting was performed at 25°C.
Analytical Ultracentrifugation
Sedimentation equilibrium analytical ultracentrifugation (SEQ) and sedimentation velocity) 
experiments were performed in an AnTi60 rotor or AnTi50 rotor respectively, at 20°C using 
a Beckman XL-I instrument. Epon double sector centerpieces and sapphire windows. The 
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protein samples were prepared in either 50 mM Tris-HCl, 300 mM NaCl, 10 mM MgCl2, 2 
mM Tris(2-carboxyethyl)phosphine and 10% (v/v) glycerol at pH 7.5 or 50 mM Tris-HCl, 
300 mM NaCl, 10 mM MgCl2, 2 mM tris(2-carboxyethyl)phosphine, 10% (v/v) glycerol, 5 
mM BeCl2 and 30 mM NaF at pH 7.5 to test the self-association of the protein(s) in the 
absence and presence of the phosphorylation mimetic Beryllofluoride (BeF3−) respectively. 
SEQ scans were using absorbance at 280 nm, after 64 h incubation at each rotor speed. The 
protein partial specific volume, solvent density and solvent viscosity were calculated using 
Sednterp 1.09 (1). SEQ scans were collected using absorbance at 280 nm, after 64 h 
incubation at each rotor speed. Sedimentation equilibrium analytical ultracentrifugation 
analysis for Efm LiaR, LiaR:BeF3−, LiaRW73C, LiaRW73C:BeF3−, LiaRRD, LiaRRD:BeF3−, 
LiaR(RD)W73C, LiaR(RD)W73C:BeF3−, LiaRDBD recorded at 13000 r.p.m., 20000 r.p.m. and 
25000 r.p.m. Data analysis was performed using Sedphat v10.58d (2,3). For each protein, the 
SEQ profiles were globally fitted to a monomer-dimer equilibrium model with rotor stretch 
and mass conservation restraints. A F-statistics error mapping approach was used to 
determine the 95% confidence intervals for the dissociation constant [41-44]. Sedimentation 
velocity (SV) data, recorded at 50000 r.p.m., was fitted using a local continuous distribution 
model looking for species between 0.5 and 15 Svedbergs with the frictional ratio, meniscus 
and bottom position allow to float to find the best fit. A single discrete species was included 
in the model with a sedimentation coefficient of 0.3 Svedbergs, to account for any buffer 
component effects. The Tikhonov regularization for the c(S) and c(M) distributions was set 
to 0.95.
DNA binding affinity determination by Microscale Thermophoresis (MST)
MST measurements were done as described previously [19, 45]. Briefly, a solution of 
unlabeled LiaR (wild type or mutants) was serially diluted in reaction buffer (50 mM Tris 
pH 7.5, 300 mM NaCl, 10 mM MgCl2, 0.3 mM DTT, 10% glycerol, 0.05% (v/v) Tween-20) 
to which an equal volume of Alexa-647 labeled DNA was added to a final concentration of 
40 nM. The samples were loaded into standard treated capillaries (Nanotemper). MST 
experiments were measured on a Monolith NT.115 system (Nanotemper Technologies) using 
30% LED and 90% IR-laser power. The resulting Kd values based on average from four 
independent MST measurements. Temperature of MST experiments was 20°C. Data 
analyses were performed using Nanotemper Analysis software, v.1.5.41. (Supplementary 
information).
Structure determination of full length LiaR activated by BeF3− 
A beryllofluoride activated LiaR protein crystal suitable for data collection was grown at 10° 
C in 0.1 M magnesium formate dehydrate, 15 % w/v Polyethylene glycol 3,350 using a 
‘microseed matrix screening’ approach [46]. Diffraction data were collected at Argonne 
National Laboratory’s Advanced Photon Source (ANL APS) beamline 21-ID-D on a 
MarMosaic 300 CCD detector. X-ray diffraction data were processed using HKL2000 [47]. 
The crystal belonged to the space group P31 with the unit cell parameters a=31.05, b=76.92, 
c=76.92, α=β=γ=90°. The 3-D structure was determined by molecular replacement using S. 
aureus receiver and DNA binding domains as the search probe in Phaser-MR [48].The 
solution from molecular replacement suggested four molecules in the asymmetric unit and a 
Matthews coefficient of 3.03 (59.5% solvent content) [49].
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The structure was refined to 3.2 Å resolution using the Phenix suite [50] and Coot [51]. The 
final values for the R=21.86 % and Rfree factors are 27.04 %. A summary of data collection 
and refinement statistic are reported in Table 3.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Research Highlights
In clinical settings, nonsusceptibility to daptomycin by Enterococcus faecium is 
correlated frequently with a mutation in LiaR of Trp73 to Cys. To elucidate the 
physicochemical basis for LiaR mediated changes in daptomycin susceptibility, we used 
a combination of biophysical and structural approaches. Our study revealed that the 
adaptive mutation W73C, even in the absence of phosphorylation, activates LiaR to 
undergo a phosphorylation-like self-dimerization event that allows LiaR to recognize and 
activate upstream regulatory regions.
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Figure 1. Beryllofluoride (BeF3−) promotes formation of Efm LiaR dimers
Sedimentation equilibrium analytical ultracentrifugation (AUC) profiles for: (a) full length 
Efm LiaR (dark blue); Efm LiaR with BeF3− (magenta); adaptive mutant Efm LiaRW73C 
(green); and adaptive mutant Efm LiaRW73C with BeF3− (cyan). (b) AUC profiles for Efm 
LiaR(RD) (blue); Efm LiaR(RD) with BeF3− (magenta); Efm LiaR(RD)W73C (green); and Efm 
LiaR(RD)W73C with BeF3− (cyan): (c) AUC profile for the DNA binding domain of Efm 
LiaR (LiaR(DBD)) alone (magenta). For each protein, the SEQ profiles were globally fitted to 
a monomer only or monomer-dimer equilibrium model.
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Figure 2. The structure of full-length Efm LiaR in complex with BeF3−/Mg2+ reveals an 
activated protein poised to bind DNA
Structural overview of the full length Efm LiaR activated with the BeF3− (PDB ID: 5HEV). 
For clarity only one of the two pairs of LiaR dimers present in the asymmetric unit are 
displayed. Receiver domain (blue) showing a molecule of BeF3− bound proximal to the 
predicted phosphorylation site (Asp54). The LiaR dimerization surface is made up of the 
α-1 and α-5 helices. Mg2+ and BeF3− are shown as spheres (red) and sticks (dark green), 
respectively. Helix α-6 makes up part of the flexible linker joining the receiver and DNA-
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binding domains (light green). The flexible linker allows the DNA binding domains to have 
a substantial amount of conformational flexibility to engage and bind to DNA.
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Figure 3. Overview of the LiaR receiver domain dimer
(a) The receiver domain forms a dimer through a hydrophobic interface of 692 Å2 that 
juxtaposes the α1 and α5 helices of two LiaR protomers; (b) LiaR active site in the presence 
of BeF3− (yellow) and Mg2+ (red). The residues Thr83 and Tyr102, adopt a characteristic 
active conformation, toward the predicted phosphorylation site at Asp54. BeF3− is also in a 
position to make hydrogen bonds to Thr82 and Ser83 and a salt bridge to Lys104; (c) Key 
residues are shown that comprise the dimerization interface in a manner comparable to that 
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observed for VraR. Met12 from one protomer docks into a hydrophobic pocket within the 
dimerization interface of the second LiaR protomer.
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Figure 4. A comparison of the DNA domain swapping observed in the E. faecium LiaR and S. 
aureus VraR structures
(a), (b) Cartoon depiction of the Efm LiaR structure (PDB ID: 5HEV) showing the receiver 
domain (RD) and DNA-binding (DBD) domains arrangements in the asymmetric unit. In the 
presence of BeF3− the crystal contained four protomers of LiaR in the asymmetric unit: A 
(green), F (yellow), B (cyan) and C (magenta). The star (red) identifies the dimerization 
interfaces of the DNA-binding domains. Two LiaR protomers (A-F and B-C) form a dimer 
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through dimerization of their receiver domains. The thin black line connecting the 
monomers identifies the dimerization interfaces of the RDs of two protomers (A-F and B-C).
(c), (d) Cartoon representation of the domain swapped arrangement in the S. aureus VraR 
activated structure (PDB ID: 4IF4). Two VraR protomers form a dimer through dimerization 
of their receiver domains (A-F and B-C), while the DNA binding domains form homodimers 
with a DNA binding domain contributed from a different receiver domain (A’-B’ and F’-C’) 
resulting in a swapping of domains. The thin black line connecting the monomers identifies 
the dimerization interfaces.
(e), (f) Cartoon representation of the domain swapping arrangement for the Efm LiaR 
activated structure (PDB ID: 5HEV). Unlike VraR, the Efm LiaR DNA binding domains 
make dimer contacts to symmetry related DNA binding domains contributed by other 
receiver domain pairs. While this arrangement of swapped domains might be an artifact of 
crystallization it also demonstrates the flexibility of the DNA binding domains in the 
activated state. The thin black line connecting the monomers identifies the dimerization 
interfaces.
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Figure 5. Efm LiaR recognizes complex upstream regulatory regions that extend beyond the 
predicted consensus sequence
DNase I Footprinting followed by Automated Capillary Electrophoresis (DFACE) was used 
to establish the Efm LiaR binding footprint within the upstream regions of the liaXYZ (−292 
to +65) and liaFSR (−281 to +98) operons of E. faecium R494. Protection studies were 
performed at 0.5, 5 and 50 μM LiaR activated with the BeF3−. DNaseI digestion patterns are 
shown as histograms (a, c, e) where negative changes in relative fluorescence units indicate 
regions of protection and positive changes indicate hypersensitivity. All DNaseI sensitivity 
data are relative to a no protein negative control.
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(a) Efm LiaR binding to the promoter region of the liaXYZ operon. Nucleotide positions 
refer to the region of LiaR binding (−120 to −75) on the DNA relative to the translation start 
site of LiaX (cyan, 5 μM LiaR; green, 50 μM LiaR).
(b/d) Oligonucleotides used for DNA binding studies (Table 2).
(c) Efm LiaR binding to the promoter region of the liaFRS operon. Nucleotide positions 
refer to the region of LiaR binding (−77 to −48) on the DNA relative to the translation start 
site of LiaF (cyan, 5 μM LiaR; blue, 50 μM LiaR).
(e) Superimposed electropherograms showing a strong and consistent hypersensitive site at 
positions −4 to −1 (AGCG) relative to the translation start site of LiaF in the presence of 
Efm LiaR (cyan, 5 μM LiaR; blue, 50 μM LiaR).
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Figure 6. Adaptive mutant LiaRW73C that confers increased daptomycin resistance in E. 
faecium binds more tightly to DNA binding sites within the liaXYZ operon
MicroScale Thermophoresis (MST) was used to measure the strength of Efm LiaR–DNA 
interactions. To determine the Kd, increasing concentrations of Efm LiaRW73C was added to 
40 nM of fluorescently labeled DNAs (Supplementary Information). Fnorm was plotted on 
the y-axis in per mil [‰] unit (meaning every 1000) against the total concentration of the 
titrated partner on a log10 scale on the x-axis [45]. The resulting Kd values based on average 
from four independent MST measurements. Bars indicate the SEM (standard error of the 
mean)
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(a) The binding of LiaRW73C to the consensus (green circles), secondary (blue diamonds), or 
entire protected region (magenta triangles) sequences within the liaXYZ operon. The DNA 
sequence for the entire protected region is shown in Figure 5b.
(b) The binding of LiaRW73C to the extended (32 bp, magenta diamonds) or entire (blue 
circles) protected regions of the liaFSR operon. The DNA sequence for the entire protected 
region is shown in Figure 5d.
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Figure 7. Mutations associated with daptomycin resistance are located within the receiver 
domain
(a) Expanded view of the Efm LiaR receiver domains showing the positions of the mutations 
W73C and S19F. The S19F mutation (yellow/cyan sticks) is within the dimerization 
interface, while the adaptive mutation W73C (yellow/cyan sticks) is not located within the 
molecular surfaces that comprise the LiaR dimer: (b) Structural alignment of the activated 
Efm LiaR receiver (blue) compared to the inactive state structures of VraR/NarL receiver 
domains (cyan/light pink). Position 73 in the VraR and NarL structures are depicted as sticks 
(cyan/light pink, respectively).
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Figure 8. Adaptive mutations in E. faecium LiaR that have been identified during antibiotic 
selection
In the absence of the cell membrane acting antibiotics or membrane stress, the three-
component regulatory system, LiaFSR, is turned “OFF.” LiaF is thought to down regulate 
the kinase activity of LiaS. Typically, LiaR is phosphorylated in response to membrane 
stress to regulate downstream target operons. E. faecium LiaR is present largely as a 
monomer at physiologically relevant concentrations. Phosphorylation may induce changes in 
the conformation of the receiver domain leading to release of DNA binding domain and 
promoting a self-dimerization event to form an active tetramer able to bind extended DNA 
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sequences. The adaptive mutation W73C, even in the absence of phosphorylation, promotes 
a phosphorylation-like self-dimerization event that increases LiaR affinity for upstream 
regulatory regions. (RD - receiver domain, DBD - DNA binding domain)
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Table 1
Dimerization affinities of E. faecium LiaR and variants in the absence and presence of BeF3−.
Protein name BeF3− Dimerization Kd (μM) 95% confidence intervals (μM)
LiaR − No dimer observed Kd> 1600
LiaR + 15 12 < Kd < 19
LiaRW73C − 182 119 <Kd < 311
LiaRW73C + 236 82 < Kd < 1000
LiaRRD − 676 497 < Kd < 986
LiaRRD + 3.4 3.2 < Kd < 4.2
LiaRRD(W73C) − 94 70 < Kd < 128
LiaRRD(W73C) + 0.8 0.4 < Kd < 1.4
LiaRDBD − 0.4 Kd < 2.0
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Table 2
DNA binding affinity of E. faecium LiaR
Protein liaXYZ
consensus
Kd (μM)
liaXYZ
secondary
Kd (μM)
liaXYZ
entire
protected
Kd (μM)
liaFSR
consensus
Kd (μM)
liaFSR
extended
Kd (μM)
liaFSR
entire
protected
Kd (μM)
Random
Kd (μM)
LiaRW73C 9.9±0.6 16.7±0.4 13.7±1.3 >100 18.2±1.1 13.3±1.3 >200
LiaR N/Da N/Da N/Da
LiaRDBD N/Da N/Da N/Da
a
no detectable binding my MST up to 450 μM LiaR, 320 μM LiaRDBD
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Table 3
Data collection and refinement statistics
Data collection
Wavelength (Å) 0.97872
Resolution (Å)a 50.0-3.2 (3.26-3.2)
Space group P31
Molecules per a.u. 4
Cell dimensions a,b,c; (Å); α, β, γ; (°) 68.03×68.03×276.95; 90×90×120
Reflections 23488
Uniquea
Average redundancya 3.5 (2.9)
Completeness (%)a 98.3 (97.9)
Rmerge (%)a,b 11.5 (0.83)
Output <I/sigI>a 10.1 (1.22)
Refinement
Rwork (%)c 21.86
Rfree (%)d 27.04
r.m.s.d.e
from ideality
Bonds (Å) 0.003
Angles (°) 0.569
Wilson B-factor (Å2) 57.6
Average B, all atoms (Å2) 53.0
Average B, ligand, BeF3− (4) (Å2) 42.5
Ramachandranf
Favored (%) 97.10
Allowed (%) 2.90
Outliers (%) 0.00
PDB ID 5HEV
aValues for the last shell are in parenthesis
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b
Rmerge = Σ|I − <I> |/ Σ I, where I is measured intensity for reflections with indices of hkl
c
Rwork = Σ|Fo − Fc |/ Σ| Fo | for all data with Fo > 2 σ (Fo) excluding data to calculate Rfree
d
Rfree = Σ|Fo − Fc |/ Σ|Fo| for all data with Fo > 2 σ (Fo) excluded from refinement.
e
Root mean square deviation
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